Literature DB >> 17170452

The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer.

Thi-Lan Tran1, Nathalie Castagné1, David Bhella2, Paloma F Varela3, Julie Bernard1, Stefan Chilmonczyk1, Stefan Berkenkamp4, Vanessa Benhamo1, Katarina Grznarova1, Jeanne Grosclaude1, Claude Nespoulos5, Felix A Rey3, Jean-François Eléouët1.   

Abstract

The respiratory syncytial virus (RSV) phosphoprotein (P) is a major polymerase co-factor that interacts with both the large polymerase fragment (L) and the nucleoprotein (N). The N-binding domain of RSV P has been investigated by co-expression of RSV P and N proteins in Escherichia coli. Pull-down assays performed with a series of truncated forms of P fused to glutathione S-transferase (GST) revealed that the region comprising the last nine C-terminal amino acid residues of P (233-DNDLSLEDF-241) is sufficient for efficient binding to N. Site-directed mutagenesis shows that the last four residues of this peptide are crucial for binding and must be present at the end of a flexible C-terminal tail. The presence of the P oligomerization domain (residues 100-160) was an important stabilizing factor for the interaction. The tetrameric full-length P fused to GST was able to pull down both helical and ring structures, whereas a monomeric C-terminal fragment of P (residues 161-241) fused to GST pulled down exclusively RNA-N rings. Electron-microscopy analysis of the purified rings showed the presence of two types of complex: undecamers (11N) and decamers (10N). Mass-spectrometry analysis of the RNA extracted from rings after RNase A treatment showed two peaks of 22,900 and 24,820 Da, corresponding to a mean RNA length of 67 and 73 bases, respectively. These results suggest strongly that each N subunit contacts 6 nt, with an extra three or four bases further protected from nuclease digestion by the ring structure at both the 5' and 3' ends.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17170452     DOI: 10.1099/vir.0.82282-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  44 in total

1.  Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein.

Authors:  Marie Galloux; Bogdan Tarus; Ilfad Blazevic; Jenna Fix; Stéphane Duquerroy; Jean-François Eléouët
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Biochemical characterization of the respiratory syncytial virus N0-P complex in solution.

Authors:  Camille Esneau; Bertrand Raynal; Pierre Roblin; Sébastien Brûlé; Charles-Adrien Richard; Jenna Fix; Jean-François Eléouët; Marie Galloux
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 3.  How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication.

Authors:  Sonia Longhi; Louis-Marie Bloyet; Stefano Gianni; Denis Gerlier
Journal:  Cell Mol Life Sci       Date:  2017-06-09       Impact factor: 9.261

4.  New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners.

Authors:  Nelson Pereira; Christophe Cardone; Safa Lassoued; Marie Galloux; Jenna Fix; Nadine Assrir; Ewen Lescop; François Bontems; Jean-François Eléouët; Christina Sizun
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

5.  Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein.

Authors:  Marie Galloux; Gaëlle Gabiane; Julien Sourimant; Charles-Adrien Richard; Patrick England; Mohammed Moudjou; Magali Aumont-Nicaise; Jenna Fix; Marie-Anne Rameix-Welti; Jean-François Eléouët
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

6.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

7.  A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.

Authors:  Pierre-Louis Hervé; Mariam Raliou; Christiane Bourdieu; Catherine Dubuquoy; Agnès Petit-Camurdan; Nicolas Bertho; Jean-François Eléouët; Christophe Chevalier; Sabine Riffault
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

8.  RSV604, a novel inhibitor of respiratory syncytial virus replication.

Authors:  Joanna Chapman; Elizabeth Abbott; Dagmar G Alber; Robert C Baxter; Sian K Bithell; Elisa A Henderson; Malcolm C Carter; Phil Chambers; Ann Chubb; G Stuart Cockerill; Peter L Collins; Verity C L Dowdell; Sally J Keegan; Richard D Kelsey; Michael J Lockyer; Cindy Luongo; Pilar Najarro; Raymond J Pickles; Mark Simmonds; Debbie Taylor; Stan Tyms; Lara J Wilson; Kenneth L Powell
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

9.  Characterization of a mumps virus nucleocapsidlike particle.

Authors:  Robert Cox; Todd J Green; Shihong Qiu; Jungsoon Kang; Jun Tsao; Peter E Prevelige; Biao He; Ming Luo
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

10.  The 24-angstrom structure of respiratory syncytial virus nucleocapsid protein-RNA decameric rings.

Authors:  Kirsty Maclellan; Colin Loney; R Paul Yeo; David Bhella
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.